Tirzepatide and semaglutide would have to drop their current net prices by 30.5% and 81.9%, respectively, to be cost-effective. Over a lifetime of use, tirzepatide could avert 45,609 obesity cases, 20 ...

Tata Motors on Thursday announced the apportionment ratio for determining the cost of acquisition of shares following the demerger of its Passenger Vehicles (PV) and Commercial Vehicles (CV) ...

Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study ...

MIAMI, November 07, 2025--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that our partner, Akeso, Inc ...

(Bloomberg) --The Trump administration said that based on “further calculations” it has determined it can provide recipients of low-income food assistance about two-thirds of their usual benefits this ...

There’s no universal safe or danger level. Ideal current ratios vary by industry. A current ratio of 1.0 means the company has $1 in current assets for every $1 in current liabilities. A ratio below 1 ...

I has made an undeniable impact throughout the healthcare industry: from a nurse navigator using an AI triage assistant to prioritize cases and respond faster, to tools to help providers document ...

The cost of health benefits per employee could climb an average of 6.5% next year — the highest increase since 2010, according to preliminary results from Mercer’s 2025 National Survey of ...

Employer health benefit plans are expected to soar in cost next year, with employees predicted to see a 6.5 percent increase in their total health benefit costs on average in 2026, a new report by the ...

UNIVERSITY PARK, Pa. — Recent laws instituted in the United States substantially cut funding to many government programs, especially those related to health or social well-being. As a health economist ...

Background: Respiratory Syncytial Virus (RSV) is the leading cause of hospitalizations in infants. The approval of nirsevimab, a long-acting monoclonal antibody, has extended the potential for RSV ...

The intersection of artificial intelligence (AI) and healthcare presents a transformative frontier, particularly in the global fight against cancer. As healthcare systems worldwide grapple with rising ...